Canada· CA-DIN-02283786
MYLAN-CILAZAPRIL
A cilazapril product containing cilazapril (cilazapril monohydrate), registered in Canada by MYLAN PHARMACEUTICALS ULC. The same ATC class is registered in 10 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Cilazapril is registered in 10 of 19 countries.
Countries holding a registration under ATC C09AA08 (cilazapril), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Cilazapril · ATC C09AA08
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of cilazapril costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.22 in Spain to $0.53 in Switzerland — a ×2.4 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cilazapril · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.53
- IT Italy$0.45
- ES Spain$0.22
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CILAZAPRIL (CILAZAPRIL MONOHYDRATE)
- Manufacturer
- MYLAN PHARMACEUTICALS ULC
- Country
- Canada (CA)
- ATC code
- C09AA08
- ATC class
- Cilazapril
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
69 interactions on record for cilazapril.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cilazapril · interactions on record
69 records
69 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Cilazapril in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomVascace 2.5mg tabletsStephar (U.K.) Ltd
- PolandCazaprolKrka, d.d., Novo mesto
- SwitzerlandInhibace
- CzechiaINHIBACECHEPLAPHARM Arzneimittel GmbH, Greifswald
- BelgiumCo-Inhibace 5 mg - 12.5 mgCheplapharm Arzneimittel
- SpainINOCAR 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULAMylan Ire Healthcare Limited
- ItalyINIBACE*14 cpr rivestite 5 mgCHEPLAPHARM ARZNEIMITTEL GMBH
- GermanyDynormCheplapharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Inhibace
- Belgium · Inhibace
- Czechia · Cazaprol, Inhibace
- Germany · Dynorm
- United Kingdom (Northern Ireland) · Cilazapril Activase Pharmaceuticals
- Greece · Vascace
- Hungary · Inhibace
- Italy · Inibace, Initiss
- Poland · Cilan, Inhibace
- Portugal · Cilazapril Generis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f77c5b71-9933-4626-bf18-2e3bba5d47ae GET /v1/drugs/f77c5b71-9933-4626-bf18-2e3bba5d47ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02283786",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "C09AA08",
"schedule": [
"Prescription"
],
"drug_code": "76936",
"strengths": [
"2.5 MG"
],
"ahfs_class": null,
"substances": [
"CILAZAPRIL (CILAZAPRIL MONOHYDRATE)"
],
"product_categorization": null
}See everything about cilazapril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.